Accenture Management Consulting
Accenture is committed to uncovering the key ingredients to help our clients become high-performance businesses. In this podcast series you will hear from Accenture Management Consulting executives regarding what businesses and public service organizations can do now to effectively manage their business for today—and for ...
Accenture is committed to uncovering the key ingredients to help our clients become high-performance businesses. In this podcast series you will hear from Accenture Management Consulting executives regarding what businesses and public service organizations can do now to effectively manage their business for today—and for tomorrow. In this podcast, Peter Lacy, who leads Accenture’s Sustainability practice across Europe, Africa and Latin America, discusses the impact of climate change, especially in the economic downturn; how companies and organizations an remain customer centric; the impact of carbon on Accenture’s business model; International policy measures that are being put into place, such as the European Union’s measures; Accenture’s Climate Change solutions for clients.
Show all Visit Show Website http://feeds2.feedburner.com/Recently Aired
-
HD
Managing a Global Workforce - Video
Accenture’s David Gartside and Rustin Richburg look at how companies ...
Accenture’s David Gartside and Rustin Richburg look at how companies can successfully manage a global workforce to support their growth strategies.
-
HD
The Process of Process Management - Audio
In this podcast, Accenture’s Mathias Kirchmer argues that business process ...
In this podcast, Accenture’s Mathias Kirchmer argues that business process management is becoming a permanent function within companies.
-
HD
The Process of Process Management - Video
In this podcast, Accenture’s Mathias Kirchmer argues that business process ...
In this podcast, Accenture’s Mathias Kirchmer argues that business process management is becoming a permanent function within companies.
-
HD
Climate Change and Health: Framing the Issue - Audio
Sir David King, GSK’s Richard Pamenter and Accenture’s Peter Lacy ...
Sir David King, GSK’s Richard Pamenter and Accenture’s Peter Lacy discuss the impact of a changing climate on human health and what this means for the Pharmaceutical and Healthcare industry.
-
HD
Climate Change and Health: Framing the Issue - Video
Sir David King, GSK’s Richard Pamenter and Accenture’s Peter Lacy ...
Sir David King, GSK’s Richard Pamenter and Accenture’s Peter Lacy discuss the impact of a changing climate on human health and what this means for the Pharmaceutical and Healthcare industry.
-
HD
The Change-Capable Organization - Audio
In this podcast, Accenture’s Walter Gossage and Andrew Leach explore ...
In this podcast, Accenture’s Walter Gossage and Andrew Leach explore how organizations can equip themselves to be change-capable.
-
HD
The Change-Capable Organization - Video
In this podcast, Accenture’s Walter Gossage and Andrew Leach explore ...
In this podcast, Accenture’s Walter Gossage and Andrew Leach explore how organizations can equip themselves to be change-capable.
-
HD
Finance and Performance Management Survey - When the Going Gets Tough, Call the CFO - Audio
The recent financial crisis has impacted the role of the ...
The recent financial crisis has impacted the role of the CFO. New research from Accenture explores the nature of the impact and what CFOs are requiring from their various capabilities and processes. Listen to this podcast to find out more.
-
HD
Finance and Performance Management Survey - When the Going Gets Tough, Call the CFO - Video
The recent financial crisis has impacted the role of the ...
The recent financial crisis has impacted the role of the CFO. New research from Accenture explores the nature of the impact and what CFOs are requiring from their various capabilities and processes. Listen to this podcast to find out more.
-
HD
Mergers & Acquisitions: A Strategy for Focused Growth in the Biopharmaceutical Industry During Uncertain Times - Audio
With an uncertain industry outlook and some cash-rich companies, it ...
With an uncertain industry outlook and some cash-rich companies, it seems likely that M&A activity will increase in the biopharmaceutical industry. In this podcast, Accenture’s Tom Herd and Arda Ural argue that a disciplined approach to M&A is vital to bu
